|
This Package Insert is
provided for product evaluation purposes only and is
not intended to be used in place of the Package Insert shipped with the product.
RETRO-TEK
HIV-1
p24 Antigen ELISA
FOR RESEARCH USE
ONLY. NOT FOR in vitro DIAGNOSTIC USE.
| |
|
|
INTENDED
USE |
|
The RETRO-TEK HIV-1
p24 Antigen ELISA is supplied for research purposes only. It is not
intended for use in the diagnosis or prognosis of disease, or for
screening and may not be used as a confirmatory test in diagnostic
situations.
The RETRO-TEK HIV-1 p24 Antigen ELISA is an
enzyme linked immunoassay used to detect Human Immunodeficiency Virus
Type 1 (HIV-1) p24 antigen in research specimens, including cell culture
media, as well as human sera and plasma. It can also be used to monitor
the purification and biochemical behavior of HIV-1.
Furthermore, the assay may augment or
supplant reverse transcriptase measurements traditionally employed to
detect the presence of HIV-1. Such enzymatic measurements are not
HIV-1-specific.
The RETRO-TEK HIV-1 ICx/CRx
Kit (ZMC Catalog #: 0801096) for immune complex dissociation and
confirmation of p24 reactivity enhances the detection of p24 antigen in
serum or plasma.
Many specimens contain HIV-1 viral loads
greater than the range of the standard curve of this assay. The
RETRO-TEK HIV-1 p24 Extended Range ELISA (ZMC catalog # 0801137) will
extend the standard curve of this assay to 4 ng/ml. |
| |
|
|
PRINCIPLE
OF THE TEST |
|
Microwells are coated
with a monoclonal antibody specific for the p24 gag gene product
of HIV-1. Viral antigen in the specimen is specifically captured onto
the immobilized antibody during specimen incubation. The captured
antigen is then reacted with a high-titered human anti-HIV-1 antibody
conjugated with biotin. Following a subsequent incubation with
Streptavidin-Peroxidase, color develops as the bound enzyme reacts with
the substrate. Resultant optical density is proportional to the amount
of HIV-1 p24 antigen present in the specimen. |
| |
|
|
|
REAGENTS |
|
Materials
Supplied:
-
HIV-1 p24
Antibody Coated Microplate for 96 determinations, 5 plates:
12x8 well strips.
-
HIV-1 p24
Detector Antibody, 5 vials, lyophilized:
Contains biotin-labeled human antibody to HIV-1, human source
material non-reactive for antibodies to HIV-1 and non-reactive for
HIV-1 p24 antigen, milk, Triton X-100®, Tween 20®,
and PBS.
-
Detector
Antibody Diluent, 5 x 25 ml:
Contains ProClin 300®.
-
HIV-1 p24
Antigen Standard, 5 x 0.5 ml:
Contains detergent-disrupted,
heat-inactivated viral antigen, goat serum, Triton X-100®,
and sodium azide.
-
Lysing Buffer,
5 x 5 ml: Triton X-100®
in PBS and 2-chloroacetamide.
-
Streptavidin-Peroxidase, 5 x 0.3 ml:
Contains streptavidin conjugated
to horseradish peroxidase, PBS, goat serum, and 2-chloroacetamide.
-
Assay Diluent,
5 x 100 ml: Contains
goat serum, PBS, Triton X-100®, and 2-chloroacetamide.
-
10X Plate Wash
Buffer, 5 x 125 ml:
Contains PBS, Tween 20®, and 2-chloroacetamide.
-
Substrate, 5 x
0.6 ml: Contains
tetramethylbenzidine (TMB), and dimethyl sulfoxide (DMSO).
-
Substrate
Buffer, 5 x 50 ml:
Contains citrate/acetate buffer, hydrogen peroxide, and
2-chloroacetamide.
-
Stop Solution,
5 x 12 ml: Proprietary
formulation.
-
Plate Sealers:
5 x 10
-
Resealable
Plastic Bag: 5
** Triton X-100® and ProClin
300® are registered trademarks of Rohm and Haas. Tween 20®
is a registered trademark of Imperial Chemical Industries.
Storage:
Store all kit reagents at 2° -
8°C. DO NOT FREEZE. When stored properly the kit is stable until the
date indicated on the box label.
Materials Required but Not Supplied:
• Disposable gloves
• Validated adjustable micropipettes, single and multichannel
• Test tubes and racks for preparing specimen and control dilutions
• Graduated cylinders and assorted beakers
• Validated automatic microplate washer or manual vacuum aspiration
equipment
• Validated incubator for 37°C ±1°C
• Validated microplate reader
• Timer
• 1% sodium hypochlorite as disinfectant. May be prepared from household
bleach
• Distilled or deionized water |
| |
|
|
|
PRECAUTIONS |
|
FOR RESEARCH USE ONLY. NOT FOR in vitro
DIAGNOSTIC USE.
• Prior to performing the assay, carefully read all instructions.
• Use universal precautions when handling kit components and test
specimens.*
• To avoid cross-contamination, use separate pipet tips for each
specimen.
• When testing potentially infectious human specimens, adhere to all
applicable local, state and federal regulations regarding the disposal
of biohazardous materials.
• HIV-1 p24 Antigen Standard contains sodium azide as a preservative.
Sodium azide may react with lead or copper pipes to form explosive metal
azides. Flush pipes with large quantities of water upon disposal to
prevent azide buildup in drains.
• Stop Solution contains hydrochloric acid which may cause severe burns.
In case of contact with eyes or skin, rinse immediately with water and
seek medical assistance.
Wear protective clothing and eye wear.
Human source material used in the manufacture of the HIV-1 Detector
Antibody has been tested and found negative for Hepatitis B surface
antigen. The viral lysate used to prepare the HIV-1 p24 Antigen Standard
has been inactivated by chemical disruption and heating. Handle these
reagents as if capable of transmitting infectious agents.
* MMWR, June 24, 1988, Vol. 37, No. 24, pp. 377-382, 387-388
* MMWR, June 24, 1988,
Vol. 37, No. 24, pp. 377-382, 387-388 |
| |
|
|
PREPARATION
OF REAGENTS |
|
HIV-1 p24
Detector Antibody:
Add 11.0 ml of Detector Antibody Diluent
to the bottle of HIV-1 p24 Detector Antibody. Mix or
rock gently for at least 1 hour. Reconstituted reagent can be stored for
one week at 2 - 8°C. Alternatively, the reconstituted HIV-1 p24 Detector
Antibody can be divided into aliquots and frozen at -20°C.
HIV-1 p24 Antigen Standard: Prepare a series of six
standards from the HIV-1 p24 Antigen Standard. Use the dilution
scheme in Table 1. Any diluted HIV-1 p24 Antigen
Standard remaining after the completion of the assay should be
disinfected and discarded. Do not save diluted reagent.
Table 1
Preparation of
HIV-1 p24 Antigen Standard
Standard
Number |
Concentration
of HIV-1 p24 (pg/ml) |
HIV-1 p24 Antigen
Standard (µl) |
Assay
Diluent (µl) |
| 1 |
125.0 |
50 |
950 |
| 2 |
62.5 |
500 of
#1 |
500 |
| 3 |
31.3 |
500 of
#2 |
500 |
| 4 |
15.6 |
500 of
#3 |
500 |
| 5 |
7.8 |
500 of
#4 |
500 |
| 6 |
0 |
0 |
500 |
Streptavidin-Peroxidase and Substrate:
To prepare the
Streptavidin-Peroxidase Working Solution and the Substrate Working
Solution, use the dilution schemes in Table 2. Use Substrate
Working Solution within 15 minutes of its preparation. Any diluted
Substrate Working Solution and Streptavidin-Peroxidase Working Solution
remaining after the completion of the assay must be discarded.
Table 2
Preparation of
Streptavidin-Peroxidase Working Solution
and Substrate Working Solution
|
|
Streptavidin-Peroxidase Working Solution |
Substrate
Working Solution |
|
Number of Strips
used |
Streptavidin-Peroxidase(µl) |
Assay Diluent
(ml) |
Substrate
(µl) |
Substrate Buffer
(ml) |
|
3 |
40 |
4.0 |
40 |
4.0 |
|
6 |
70 |
7.0 |
70 |
7.0 |
|
9 |
100 |
10.0 |
100 |
1.0 |
|
12 |
120 |
12.0 |
120 |
12.0 |
Plate Wash
Buffer: Dilute 10X Plate Wash Buffer 1:10 in distilled
or deionized water prior to use. 1X Plate Wash Buffer may be stored at
2° - 8°C for up to 1 week. Additional bottles of 10X Plate Wash Buffer
(ZMC Catalog # 0801060) may be ordered. |
| |
|
|
TEST
PROCEDURE |
|
When
assaying serum or plasma samples, sensitivity may be increased by using
the RETRO-TEK HIV-1 p24 ICx/CRx Kit, (ZMC Catalog
#: 0801096) to dissociate possible immune complexes. Reactive specimens
should be confirmed using the ICx/CRx Kit
confirmatory reagents.
Allow all reagents to reach room
temperature before use. Label test tubes to be used for the preparation
of standards and specimens. Label each strip on its end tab to identify
the strips should they become detached from the plate frame during the
assay. If the entire 96 well plate will not be used, remove surplus
strips from the plate frame. Place surplus strips and desiccant into the
Resealable Plastic Bag, seal and store at 2° - 8°C.
Step 1: Treat specimens in
a test tube by pipetting 50 µl of Lysing Buffer into
450 µl specimen and mix well.
Step 2:
Wash each well of the microplate or the selected number of strips 6
times with 300 µl of 1X Plate Wash Buffer and aspirate.
Thoroughly blot by striking inverted microplate or strips on a pad of
absorbent towels. Continue striking until no droplets remain in the
wells. Do not allow washed plates
to dry completely prior to sample addition. Drying will adversely affect
test results.
Step 3: Leave one well of
the microtiter plate empty during the assay. This well is used for a
substrate blank. Pipet 200 µl of standards #1-6 into
duplicate wells.
Step 4: Pipet 200 µl
of each specimen, as prepared in Step 1, into duplicate
wells.
Step 5: Cover
microplate with a plate sealer and incubate as follows:
Cover microplate with a plate sealer and incubate
as follows:
a. Overnight at 37°C ± 1°C, for serum
or plasma
specimens treated with RETRO-TEK HIV-1
ICx/CRx Kit.
b. Two hours at 37°C ± 1°C, for
untreated
serum or plasma, culture fluids or other
biological specimens.
Step 6: Aspirate and wash
plate as described in Step 2.
Step 7: Pipet 100 µl
of reconstituted HIV-1 p24 Detector Antibody into each well,
except the substrate blank. Cover the microplate with a sealer and
incubate for 1 hour at 37°C ± 1°C.
Step 8: Aspirate and wash
plate as described in Step 2.
Step 9: Pipet 100 µl
of the Streptavidin-Peroxidase Working Solution into each well
except the substrate blank. Cover the microplate with a sealer and
incubate for 30 minutes at 37°C ± 1°C.
Step 10: Aspirate and wash
plate as described in Step 2.
Step 11: Pipet 100 µl
of Substrate Working Solution into all wells and incubate
uncovered for 30 minutes at room temperature (18°-
25°C). A blue color will develop in wells containing viral antigen.
Step 12: Stop the reaction
by pipetting 100 µl of Stop Solution into each well. A color
change from blue to yellow will result.
Step 13: Within 15
minutes, read the optical density of each well at 450 nm
using a microplate reader. |
| |
|
|
TEST
VALIDITY |
|
Determine the mean
optical density values for each standard and specimen. For the test to
be valid, it must meet the following criteria:
• The mean optical density of the 0 pg/ml standard and the substrate
blank
must be less than 0.100.
• The mean optical density of the 62.5 pg/ml standard must be greater
than
or equal to 0.500
Additional Validity Requirements for the RETRO-TEK HIV-1 ICx/CRx
Kit
• For immune complex dissociation, the positive control must be above
the
cut-off for immune complex dissociated specimens and the negative
control must be below the cut-off for immune complex dissociated
specimens.
• After treatment with the CRx
Neutralization Reagent, the level of the
Positive Control must be reduced by at least 50% and the level of the
Negative Control must be below the cut-off. |
| |
|
|
|
CALCULATION
AND
INTERPRETATION
OF RESULTS |
|
Determination of the Cutoff Value:
A predetermined factor is added to the mean of the
negative control or negative specimen sample optical value.
• For non-immune complex dissociated serum or
plasma samples, and tissue culture samples add 0.030.
• For immune complex dissociated serum or plasma
samples add 0.050.
The values above are general guidelines to
determine the cutoff value. Alternatively, more accurate results may be
obtained by adding at least two standard deviations to the mean optical
density from a set of known negative specimen samples to establish the
statistical cutoff value.
Samples with absorbance values greater than or
equal to the cutoff value are considered positive. Positive results must
be confirmed by retesting in duplicate from the same sample source.
Specimens found to be repeatedly reactive for p24
should be confirmed using the CRx Neutralization Procedure.
Refer to Catalog #: 0801096 (RETRO-TEK ICx /CRx
Kit).
For confirmation of reactivity by the RETRO-TEK ICx
/CRx Kit, calculate the percent reduction of p24 reactivity
in controls and specimens using the formula in Figure 1:
Figure 1:
Reactivity is confirmed by a reduction of p24
antigen in the specimen by 50% or greater. If reactivity is not
confirmed, the specimen is considered indeterminate.
To Quantitate Levels of HIV-1 p24 :
Using linear graph paper, plot the concentration
of HIV-1 p24 Antigen Standard (pg/ml) on the X-axis versus the mean
optical densities for each standard on the Y-axis. Then determine the
concentration of HIV-1 p24 antigen in specimens by interpolation from
the standard curve. Alternatively, the level of HIV-1 p24 may be
calculated by computer using a point-to-point algorithm. Be sure to
correct for all dilutions, including the 1 to 1.1 dilution made during
the addition of Lysing Buffer.
TYPICAL STANDARD CURVE
|
HIV-1 Antigen
Concentration |
Avg. OD at 450nm in
overnight assay* |
|
125.00 |
1.315 |
|
62.50 |
0.840 |
|
31.25 |
0.508 |
|
15.60 |
0.304 |
|
7.80 |
0.184 |
|
0.00 |
0.055 |
*2 hour assay values may
be less than the overnight results.
Standard curves may vary as a result of incubation time
and temperature, laboratory temperature, etc. |
| |
|
|
LIMITATIONS
OF THE
PROCEDURE |
|
Most HIV-1 infected
individuals produce antibodies to p24 antigen. The concentration and
microspecificity of these antibodies will vary from individual to
individual and from bleed to bleed. The observed level of p24 antigen in
any specimen containing p24 antibodies may be affected by the following:
• Host antibodies may mask the
epitope reactive with capture MAb.
Consequently, the optical density may be reduced.
• Host antibodies may mask
epitopes that bind to the detector antibody,
again reducing the optical density.
After immune complex dissociation
and neutralization, host antibodies may recombine with p24 antigen. The
recombination of host antibody with antigen is competitive with the
capture of p24 by the MAb on the solid phase and thus may mask some of
the p24. The rate of recombination is determined by the concentrations
of p24 antigen and anti-p24 antibodies, the affinity of the antibodies,
as well as temperature and time and is therefore difficult to control.
Correlation of results for specimens between repeat test runs and among
kits from different manufacturers may be adversely affected by such
competetive recombination. |
| |
|
|
PROCEDURAL
FLOW CHART |
|
| |
PREPARE REAGENTS |
|
| |
WASH PLATE |
|
| |
PIPET SPECIMENS,
STANDARDS AND CONTROLS |
|
FOR TREATED
SERUM OR PLASMA |
|
FOR UNTREATED
SERUM, PLASMA
AND OTHER
SPECIMENS |
|
INCUBATE OVERNIGHT AT 37º
+ 1ºC |
|
INCUBATE 2 HOURS
AT 37º + 1ºC |
| |
WASH PLATE |
|
| |
PIPET DETECTOR ANTIBODY |
|
| |
INCUBATE 1 HOUR AT AT 37º
+ 1ºC |
|
| |
WASH PLATE |
|
| |
PIPET STREPTAVIDIN
PEROXIDASE SOLUTION |
|
| |
INCUBATE 30 MINUTES AT AT
37º + 1ºC |
|
| |
WASH PLATE |
|
| |
PIPET SUBSTRATE SOLUTION |
|
| |
INCUBATE 30 MINUTES AT
ROOM TEMPERATURE |
|
| |
ADD STOP SOLUTION AND
READ AT 450 NM |
|
|
| |
|
|
Rev 08/05
|